Fan X, Dai X, Ling Y, Wu L, et al. Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study. Lancet Infect Dis 2023 Nov 22:S1473-3099(23)00577.
PMID: 38006892